HTG MOLECULAR DIAGNOSTICS (HTGM) Stock Price, Forecast & Analysis
USA - NASDAQ:HTGM - US40434H3021 - Common Stock
HTGM Key Statistics, Chart & Performance
The current stock price of HTGM is 0.48 USD. In the past month the price decreased by -81.32%. In the past year, price decreased by -92.79%.
HTGM Latest News, Press Relases and Analysis
HTGM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.58 | 48.33B | ||
| DOCS | DOXIMITY INC-CLASS A | 33.1 | 10.17B | ||
| WAY | WAYSTAR HOLDING CORP | 27.03 | 6.91B | ||
| HTFL | HEARTFLOW INC | N/A | 2.72B | ||
| CERT | CERTARA INC | 17.34 | 1.39B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.33B | ||
| PHR | PHREESIA INC | N/A | 1.32B | ||
| SDGR | SCHRODINGER INC | N/A | 1.31B | ||
| CTEV | CLARITEV CORP | N/A | 1.14B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.89 | 1.08B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 530.75 | 898.45M |
Related stock screener links
About HTGM
Company Profile
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.
Company Info
HTG MOLECULAR DIAGNOSTICS
3430 E Global Loop
Tucson ARIZONA 85706 US
CEO: John L. Lubniewski
Employees: 53
Phone: 18772892615.0
HTG MOLECULAR DIAGNOSTICS / HTGM FAQ
What does HTG MOLECULAR DIAGNOSTICS do?
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.
Can you provide the latest stock price for HTG MOLECULAR DIAGNOSTICS?
The current stock price of HTGM is 0.48 USD. The price decreased by -20% in the last trading session.
Does HTG MOLECULAR DIAGNOSTICS pay dividends?
HTGM does not pay a dividend.
How is the ChartMill rating for HTG MOLECULAR DIAGNOSTICS?
HTGM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is HTGM stock listed?
HTGM stock is listed on the Nasdaq exchange.
What is the market capitalization of HTGM stock?
HTG MOLECULAR DIAGNOSTICS (HTGM) has a market capitalization of 1.06M USD. This makes HTGM a Nano Cap stock.
Can you provide the ownership details for HTGM stock?
You can find the ownership structure of HTG MOLECULAR DIAGNOSTICS (HTGM) on the Ownership tab.
HTGM Technical Analysis
HTGM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HTGM. HTGM has a bad profitability rating. Also its financial health evaluation is rather negative.
HTGM Financial Highlights
Over the last trailing twelve months HTGM reported a non-GAAP Earnings per Share(EPS) of -18.15. The EPS increased by 44.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 7.1 |
HTGM Forecast & Estimates
7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.
For the next year, analysts expect an EPS growth of 81.55% and a revenue growth 0.6% for HTGM